Darla Hess
Psychiatric/Mental Health · Tyler, TXNPI 1396473898
Payments from drug & device makers
Across 240 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$952
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$710
- Vanda Pharmaceuticals Inc.$659
- AbbVie$578
- Johnson & Johnson$392
- plus $2K from 12 others
What the payments were for
- Food & beverage$6,09998%
- Education$1172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 56 | $1,318 |
| Teva Pharmaceuticals USA, Inc. | 28 | $952 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $710 |
| Vanda Pharmaceuticals Inc. | 23 | $659 |
| AbbVie | 29 | $578 |
| Johnson & Johnson | 4 | $392 |
| Idorsia Pharmaceuticals US Inc | 11 | $352 |
| Otsuka America Pharmaceutical, Inc. | 13 | $337 |
| E.r. Squibb & Sons, L.L.C. | 12 | $327 |
| Alkermes, Inc. | 12 | $295 |
| Supernus Pharmaceuticals, Inc. | 18 | $176 |
| Gilead | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Bayer | 1 | $16 |
| Indivior Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,216 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 40 | $337,515 |
| IngrezzaValbenazine Tosylate | 14 | $114,287 |
| AustedoDeutetrabenazine | 12 | $67,967 |
| VraylarCariprazine Hcl | 32 | $45,475 |
| LybalviOlanzapine/Samidorphan Malate | 18 | $31,784 |
| CaplytaLumateperone Tosylate | 19 | $31,498 |
| Fluphenazine Hcl | 20 | $3,303 |
| Quetiapine Fumarate | 83 | $1,649 |
| Atomoxetine Hcl | 17 | $1,267 |
| Ziprasidone Hcl | 16 | $1,070 |
| Doxepin Hcl | 17 | $1,020 |
| Trazodone Hcl | 160 | $909 |
| Aripiprazole | 32 | $767 |
| Clonazepam | 70 | $659 |
| Hydroxyzine Hcl | 38 | $616 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $952 | $405,48252 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,318 | $114,28714 claims |
| AbbVieVraylar | $578 | $45,47532 claims |
| Alkermes, Inc.Lybalvi | $295 | $31,78418 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $710 | $31,49819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Tyler
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.